All the news articles and press releases in one place.

Search
Date / Time Source Ticker Company Sector Market Cap Announcement
04Aug20 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Trading update
31Jul20 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Physiomics awarded contract by Astellas Pharma Inc
22Jul20 11:45 RNS PYC:LON Physiomics Plc Other £2.10m Share Price Movement
06Jul20 10:00 RNS PYC:LON Physiomics Plc Other £2.10m Director dealing
30Jun20 14:30 RNS PYC:LON Physiomics Plc Other £2.10m Contract award and update
22Jun20 07:00 RNS-R PYC:LON Physiomics Plc Other £2.10m Conference presentation
10Jun20 13:00 RNS PYC:LON Physiomics Plc Other £2.10m Holding(s) in Company
27May20 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Fundraise
15May20 13:00 RNS PYC:LON Physiomics Plc Other £2.10m Holding(s) in Company
28Apr20 14:50 RNS-R PYC:LON Physiomics Plc Other £2.10m Conference attendance and presentation
16Apr20 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Confirmation of Twitter account
09Apr20 12:28 RNS PYC:LON Physiomics Plc Other £2.10m Holding(s) in Company
06Apr20 07:00 RNS-R PYC:LON Physiomics Plc Other £2.10m Awarded further Bicycle Therapeutics contract
19Mar20 07:00 RNS PYC:LON Physiomics Plc Other £2.10m COVID-19 update
10Mar20 07:00 RNS PYC:LON Physiomics Plc Other £2.10m NIHR i4i award
05Mar20 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Physiomics awarded further contract by Merck
03Mar20 07:01 RNS PYC:LON Physiomics Plc Other £2.10m Interim Results
03Mar20 07:00 RNS-R PYC:LON Physiomics Plc Other £2.10m Awarded two further contracts by Bicycle
27Dec19 15:45 RNS PYC:LON Physiomics Plc Other £2.10m Holding(s) in Company
23Dec19 07:00 RNS-R PYC:LON Physiomics Plc Other £2.10m Contract award
20Dec19 10:30 RNS PYC:LON Physiomics Plc Other £2.10m Merck Contracts
19Nov19 12:52 RNS PYC:LON Physiomics Plc Other £2.10m Result of AGM
21Oct19 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Dispatch of Annual Report and Notice of AGM
30Sep19 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Final Results for the Year Ended 30 June 2019
05Aug19 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Director Dealing
30Jul19 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Trading Update
22Jul19 09:03 RNS PYC:LON Physiomics Plc Other £2.10m Holding(s) in Company
08Jul19 07:00 RNS-R PYC:LON Physiomics Plc Other £2.10m Agreement with Bicycle and Cancer Research UK
02Jul19 13:30 RNS PYC:LON Physiomics Plc Other £2.10m Holding(s) in Company
28Jun19 07:00 RNS-R PYC:LON Physiomics Plc Other £2.10m Contract Award
31May19 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Change of Adviser
14May19 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Innovate UK Award Project
03May19 12:00 RNS-R PYC:LON Physiomics Plc Other £2.10m Physiomics participates at NIHR event
30Apr19 14:00 RNS-R PYC:LON Physiomics Plc Other £2.10m Conference attendance and presentation
27Mar19 13:00 RNS PYC:LON Physiomics Plc Other £2.10m Issue of Options
26Mar19 13:00 RNS PYC:LON Physiomics Plc Other £2.10m AIM Rule 26 Website Change
20Mar19 07:00 RNS-R PYC:LON Physiomics Plc Other £2.10m Conference Attendance and Presentation
21Feb19 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Interim Results
07Jan19 07:00 RNS-R PYC:LON Physiomics Plc Other £2.10m Conference Attendance
03Jan19 07:00 RNS-R PYC:LON Physiomics Plc Other £2.10m Strategic Collaboration
17Dec18 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Renewal of Agreement with Merck
20Nov18 12:56 RNS PYC:LON Physiomics Plc Other £2.10m Result of AGM
15Oct18 13:00 RNS PYC:LON Physiomics Plc Other £2.10m Dispatch of Annual Report and Shareholder Circular
08Oct18 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Final Results for the Year Ended 30 June 2018
09Aug18 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Contract award
21Jun18 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Trading Update
23May18 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Placing
26Apr18 11:06 RNS PYC:LON Physiomics Plc Other £2.10m Contract Award
06Apr18 14:40 RNS PYC:LON Physiomics Plc Other £2.10m Director/PDMR Shareholding
27Mar18 17:23 RNS PYC:LON Physiomics Plc Other £2.10m Issue of Options
14Mar18 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Award of New Innovate UK Grant
19Feb18 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Interim Results Statement
09Feb18 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Contract Award
26Jan18 07:00 RNS PYC:LON Physiomics Plc Other £2.10m New Major Pharmaceutical Client
25Jan18 13:34 RNS PYC:LON Physiomics Plc Other £2.10m Holding(s) in Company
24Jan18 08:46 RNS PYC:LON Physiomics Plc Other £2.10m Holding(s) in Company
19Jan18 10:20 RNS PYC:LON Physiomics Plc Other £2.10m Holding(s) in Company
17Jan18 15:52 RNS PYC:LON Physiomics Plc Other £2.10m Holding(s) in Company
13Dec17 14:06 RNS PYC:LON Physiomics Plc Other £2.10m Result of AGM
12Dec17 10:17 RNS PYC:LON Physiomics Plc Other £2.10m Director Dealing
06Dec17 15:00 RNS PYC:LON Physiomics Plc Other £2.10m Issue of Equity
30Nov17 13:38 RNS PYC:LON Physiomics Plc Other £2.10m Share Price Movement
28Nov17 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Clinical Project Completion and Services Agreement
09Nov17 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Dispatch of Annual Report and Shareholder Circular
16Oct17 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Final Results
02Oct17 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Company Update
31Jul17 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Two New Pre-Clinical Contracts
05May17 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Physiomics to Present at BioTrinity 2017
24Mar17 11:15 RNS PYC:LON Physiomics Plc Other £2.10m Interim Results Statement
11Jan17 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Company Update
06Jan17 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Confirmation of Award of Innovate UK Grant
22Dec16 15:31 RNS PYC:LON Physiomics Plc Other £2.10m Director Dealing
22Dec16 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Issue of Options
16Dec16 13:00 RNS PYC:LON Physiomics Plc Other £2.10m Result of AGM
05Dec16 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Payment for in-silico modelling of inhibitor
23Nov16 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Posting of Financial Results and Notice of AGM
22Nov16 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Provisional Award of Innovate UK Grant
27Oct16 15:00 RNS PYC:LON Physiomics Plc Other £2.10m Final Results for the year ended 30 June 2016
25Oct16 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Directorate Change
28Sep16 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Advisor Changes
21Sep16 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Placing and Update on Acquisition
07Sep16 12:19 RNS PYC:LON Physiomics Plc Other £2.10m Result of GM
22Aug16 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Notice of General Meeting
16Aug16 13:05 RNS PYC:LON Physiomics Plc Other £2.10m Advisor Changes
16May16 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Extensions for Virtual Tumour Project
18Apr16 09:02 RNS PYC:LON Physiomics Plc Other £2.10m Physiomics Appoints New Chief Executive Officer
04Apr16 12:12 RNS PYC:LON Physiomics Plc Other £2.10m New Speciality Pharma Customer for new Indication
31Mar16 07:01 RNS PYC:LON Physiomics Plc Other £2.10m Interim Results Statement
31Mar16 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Heads of Terms with BioMoti and Board Changes
22Dec15 12:08 RNS PYC:LON Physiomics Plc Other £2.10m Issue of Options
22Dec15 07:00 RNS PYC:LON Physiomics Plc Other £2.10m New Speciality Pharma Customer for New Indication
18Dec15 10:57 RNS PYC:LON Physiomics Plc Other £2.10m Placing
14Dec15 10:29 RNS PYC:LON Physiomics Plc Other £2.10m Result of General Meeting
27Nov15 16:15 RNS PYC:LON Physiomics Plc Other £2.10m Notice of General Meeting
10Nov15 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Final Results
06Nov15 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Strategic Update
12Oct15 07:00 RNS PYC:LON Physiomics Plc Other £2.10m 4th Large Pharma Customer for Virtual Tumour
09Oct15 07:00 RNS PYC:LON Physiomics Plc Other £2.10m Project extension with global pharma company
Date / Time Source Company % Chg
04Aug20 07:00 RNS Physiomics Plc 14.81%
Trading update
31Jul20 07:00 RNS Physiomics Plc 14.81%
Physiomics awarded contract by Astellas Pharma Inc
22Jul20 11:45 RNS Physiomics Plc 14.81%
Share Price Movement
06Jul20 10:00 RNS Physiomics Plc 14.81%
Director dealing
30Jun20 14:30 RNS Physiomics Plc 14.81%
Contract award and update
22Jun20 07:00 RNS-R Physiomics Plc 14.81%
Conference presentation
10Jun20 13:00 RNS Physiomics Plc 14.81%
Holding(s) in Company
27May20 07:00 RNS Physiomics Plc 14.81%
Fundraise
15May20 13:00 RNS Physiomics Plc 14.81%
Holding(s) in Company
28Apr20 14:50 RNS-R Physiomics Plc 14.81%
Conference attendance and presentation
16Apr20 07:00 RNS Physiomics Plc 14.81%
Confirmation of Twitter account
09Apr20 12:28 RNS Physiomics Plc 14.81%
Holding(s) in Company
06Apr20 07:00 RNS-R Physiomics Plc 14.81%
Awarded further Bicycle Therapeutics contract
19Mar20 07:00 RNS Physiomics Plc 14.81%
COVID-19 update
10Mar20 07:00 RNS Physiomics Plc 14.81%
NIHR i4i award
05Mar20 07:00 RNS Physiomics Plc 14.81%
Physiomics awarded further contract by Merck
03Mar20 07:01 RNS Physiomics Plc 14.81%
Interim Results
03Mar20 07:00 RNS-R Physiomics Plc 14.81%
Awarded two further contracts by Bicycle
27Dec19 15:45 RNS Physiomics Plc 14.81%
Holding(s) in Company
23Dec19 07:00 RNS-R Physiomics Plc 14.81%
Contract award
20Dec19 10:30 RNS Physiomics Plc 14.81%
Merck Contracts
19Nov19 12:52 RNS Physiomics Plc 14.81%
Result of AGM
21Oct19 07:00 RNS Physiomics Plc 14.81%
Dispatch of Annual Report and Notice of AGM
30Sep19 07:00 RNS Physiomics Plc 14.81%
Final Results for the Year Ended 30 June 2019
05Aug19 07:00 RNS Physiomics Plc 14.81%
Director Dealing
30Jul19 07:00 RNS Physiomics Plc 14.81%
Trading Update
22Jul19 09:03 RNS Physiomics Plc 14.81%
Holding(s) in Company
08Jul19 07:00 RNS-R Physiomics Plc 14.81%
Agreement with Bicycle and Cancer Research UK
02Jul19 13:30 RNS Physiomics Plc 14.81%
Holding(s) in Company
28Jun19 07:00 RNS-R Physiomics Plc 14.81%
Contract Award
31May19 07:00 RNS Physiomics Plc 14.81%
Change of Adviser
14May19 07:00 RNS Physiomics Plc 14.81%
Innovate UK Award Project
03May19 12:00 RNS-R Physiomics Plc 14.81%
Physiomics participates at NIHR event
30Apr19 14:00 RNS-R Physiomics Plc 14.81%
Conference attendance and presentation
27Mar19 13:00 RNS Physiomics Plc 14.81%
Issue of Options
26Mar19 13:00 RNS Physiomics Plc 14.81%
AIM Rule 26 Website Change
20Mar19 07:00 RNS-R Physiomics Plc 14.81%
Conference Attendance and Presentation
21Feb19 07:00 RNS Physiomics Plc 14.81%
Interim Results
07Jan19 07:00 RNS-R Physiomics Plc 14.81%
Conference Attendance
03Jan19 07:00 RNS-R Physiomics Plc 14.81%
Strategic Collaboration
17Dec18 07:00 RNS Physiomics Plc 14.81%
Renewal of Agreement with Merck
20Nov18 12:56 RNS Physiomics Plc 14.81%
Result of AGM
15Oct18 13:00 RNS Physiomics Plc 14.81%
Dispatch of Annual Report and Shareholder Circular
08Oct18 07:00 RNS Physiomics Plc 14.81%
Final Results for the Year Ended 30 June 2018
09Aug18 07:00 RNS Physiomics Plc 14.81%
Contract award
21Jun18 07:00 RNS Physiomics Plc 14.81%
Trading Update
23May18 07:00 RNS Physiomics Plc 14.81%
Placing
26Apr18 11:06 RNS Physiomics Plc 14.81%
Contract Award
06Apr18 14:40 RNS Physiomics Plc 14.81%
Director/PDMR Shareholding
27Mar18 17:23 RNS Physiomics Plc 14.81%
Issue of Options
14Mar18 07:00 RNS Physiomics Plc 14.81%
Award of New Innovate UK Grant
19Feb18 07:00 RNS Physiomics Plc 14.81%
Interim Results Statement
09Feb18 07:00 RNS Physiomics Plc 14.81%
Contract Award
26Jan18 07:00 RNS Physiomics Plc 14.81%
New Major Pharmaceutical Client
25Jan18 13:34 RNS Physiomics Plc 14.81%
Holding(s) in Company
24Jan18 08:46 RNS Physiomics Plc 14.81%
Holding(s) in Company
19Jan18 10:20 RNS Physiomics Plc 14.81%
Holding(s) in Company
17Jan18 15:52 RNS Physiomics Plc 14.81%
Holding(s) in Company
13Dec17 14:06 RNS Physiomics Plc 14.81%
Result of AGM
12Dec17 10:17 RNS Physiomics Plc 14.81%
Director Dealing
06Dec17 15:00 RNS Physiomics Plc 14.81%
Issue of Equity
30Nov17 13:38 RNS Physiomics Plc 14.81%
Share Price Movement
28Nov17 07:00 RNS Physiomics Plc 14.81%
Clinical Project Completion and Services Agreement
09Nov17 07:00 RNS Physiomics Plc 14.81%
Dispatch of Annual Report and Shareholder Circular
16Oct17 07:00 RNS Physiomics Plc 14.81%
Final Results
02Oct17 07:00 RNS Physiomics Plc 14.81%
Company Update
31Jul17 07:00 RNS Physiomics Plc 14.81%
Two New Pre-Clinical Contracts
05May17 07:00 RNS Physiomics Plc 14.81%
Physiomics to Present at BioTrinity 2017
24Mar17 11:15 RNS Physiomics Plc 14.81%
Interim Results Statement
11Jan17 07:00 RNS Physiomics Plc 14.81%
Company Update
06Jan17 07:00 RNS Physiomics Plc 14.81%
Confirmation of Award of Innovate UK Grant
22Dec16 15:31 RNS Physiomics Plc 14.81%
Director Dealing
22Dec16 07:00 RNS Physiomics Plc 14.81%
Issue of Options
16Dec16 13:00 RNS Physiomics Plc 14.81%
Result of AGM
05Dec16 07:00 RNS Physiomics Plc 14.81%
Payment for in-silico modelling of inhibitor
23Nov16 07:00 RNS Physiomics Plc 14.81%
Posting of Financial Results and Notice of AGM
22Nov16 07:00 RNS Physiomics Plc 14.81%
Provisional Award of Innovate UK Grant
27Oct16 15:00 RNS Physiomics Plc 14.81%
Final Results for the year ended 30 June 2016
25Oct16 07:00 RNS Physiomics Plc 14.81%
Directorate Change
28Sep16 07:00 RNS Physiomics Plc 14.81%
Advisor Changes
21Sep16 07:00 RNS Physiomics Plc 14.81%
Placing and Update on Acquisition
07Sep16 12:19 RNS Physiomics Plc 14.81%
Result of GM
22Aug16 07:00 RNS Physiomics Plc 14.81%
Notice of General Meeting
16Aug16 13:05 RNS Physiomics Plc 14.81%
Advisor Changes
16May16 07:00 RNS Physiomics Plc 14.81%
Extensions for Virtual Tumour Project
18Apr16 09:02 RNS Physiomics Plc 14.81%
Physiomics Appoints New Chief Executive Officer
04Apr16 12:12 RNS Physiomics Plc 14.81%
New Speciality Pharma Customer for new Indication
31Mar16 07:01 RNS Physiomics Plc 14.81%
Interim Results Statement
31Mar16 07:00 RNS Physiomics Plc 14.81%
Heads of Terms with BioMoti and Board Changes
22Dec15 12:08 RNS Physiomics Plc 14.81%
Issue of Options
22Dec15 07:00 RNS Physiomics Plc 14.81%
New Speciality Pharma Customer for New Indication
18Dec15 10:57 RNS Physiomics Plc 14.81%
Placing
14Dec15 10:29 RNS Physiomics Plc 14.81%
Result of General Meeting
27Nov15 16:15 RNS Physiomics Plc 14.81%
Notice of General Meeting
10Nov15 07:00 RNS Physiomics Plc 14.81%
Final Results
06Nov15 07:00 RNS Physiomics Plc 14.81%
Strategic Update
12Oct15 07:00 RNS Physiomics Plc 14.81%
4th Large Pharma Customer for Virtual Tumour
09Oct15 07:00 RNS Physiomics Plc 14.81%
Project extension with global pharma company
Date / Time Company % Chg
04Aug20 07:00 Physiomics Plc 14.81%
Trading update
31Jul20 07:00 Physiomics Plc 14.81%
Physiomics awarded contract by Astellas Pharma Inc
22Jul20 11:45 Physiomics Plc 14.81%
Share Price Movement
06Jul20 10:00 Physiomics Plc 14.81%
Director dealing
30Jun20 14:30 Physiomics Plc 14.81%
Contract award and update
22Jun20 07:00 Physiomics Plc 14.81%
Conference presentation
10Jun20 13:00 Physiomics Plc 14.81%
Holding(s) in Company
27May20 07:00 Physiomics Plc 14.81%
Fundraise
15May20 13:00 Physiomics Plc 14.81%
Holding(s) in Company
28Apr20 14:50 Physiomics Plc 14.81%
Conference attendance and presentation
16Apr20 07:00 Physiomics Plc 14.81%
Confirmation of Twitter account
09Apr20 12:28 Physiomics Plc 14.81%
Holding(s) in Company
06Apr20 07:00 Physiomics Plc 14.81%
Awarded further Bicycle Therapeutics contract
19Mar20 07:00 Physiomics Plc 14.81%
COVID-19 update
10Mar20 07:00 Physiomics Plc 14.81%
NIHR i4i award
05Mar20 07:00 Physiomics Plc 14.81%
Physiomics awarded further contract by Merck
03Mar20 07:01 Physiomics Plc 14.81%
Interim Results
03Mar20 07:00 Physiomics Plc 14.81%
Awarded two further contracts by Bicycle
27Dec19 15:45 Physiomics Plc 14.81%
Holding(s) in Company
23Dec19 07:00 Physiomics Plc 14.81%
Contract award
20Dec19 10:30 Physiomics Plc 14.81%
Merck Contracts
19Nov19 12:52 Physiomics Plc 14.81%
Result of AGM
21Oct19 07:00 Physiomics Plc 14.81%
Dispatch of Annual Report and Notice of AGM
30Sep19 07:00 Physiomics Plc 14.81%
Final Results for the Year Ended 30 June 2019
05Aug19 07:00 Physiomics Plc 14.81%
Director Dealing
30Jul19 07:00 Physiomics Plc 14.81%
Trading Update
22Jul19 09:03 Physiomics Plc 14.81%
Holding(s) in Company
08Jul19 07:00 Physiomics Plc 14.81%
Agreement with Bicycle and Cancer Research UK
02Jul19 13:30 Physiomics Plc 14.81%
Holding(s) in Company
28Jun19 07:00 Physiomics Plc 14.81%
Contract Award
31May19 07:00 Physiomics Plc 14.81%
Change of Adviser
14May19 07:00 Physiomics Plc 14.81%
Innovate UK Award Project
03May19 12:00 Physiomics Plc 14.81%
Physiomics participates at NIHR event
30Apr19 14:00 Physiomics Plc 14.81%
Conference attendance and presentation
27Mar19 13:00 Physiomics Plc 14.81%
Issue of Options
26Mar19 13:00 Physiomics Plc 14.81%
AIM Rule 26 Website Change
20Mar19 07:00 Physiomics Plc 14.81%
Conference Attendance and Presentation
21Feb19 07:00 Physiomics Plc 14.81%
Interim Results
07Jan19 07:00 Physiomics Plc 14.81%
Conference Attendance
03Jan19 07:00 Physiomics Plc 14.81%
Strategic Collaboration
17Dec18 07:00 Physiomics Plc 14.81%
Renewal of Agreement with Merck
20Nov18 12:56 Physiomics Plc 14.81%
Result of AGM
15Oct18 13:00 Physiomics Plc 14.81%
Dispatch of Annual Report and Shareholder Circular
08Oct18 07:00 Physiomics Plc 14.81%
Final Results for the Year Ended 30 June 2018
09Aug18 07:00 Physiomics Plc 14.81%
Contract award
21Jun18 07:00 Physiomics Plc 14.81%
Trading Update
23May18 07:00 Physiomics Plc 14.81%
Placing
26Apr18 11:06 Physiomics Plc 14.81%
Contract Award
06Apr18 14:40 Physiomics Plc 14.81%
Director/PDMR Shareholding
27Mar18 17:23 Physiomics Plc 14.81%
Issue of Options
14Mar18 07:00 Physiomics Plc 14.81%
Award of New Innovate UK Grant
19Feb18 07:00 Physiomics Plc 14.81%
Interim Results Statement
09Feb18 07:00 Physiomics Plc 14.81%
Contract Award
26Jan18 07:00 Physiomics Plc 14.81%
New Major Pharmaceutical Client
25Jan18 13:34 Physiomics Plc 14.81%
Holding(s) in Company
24Jan18 08:46 Physiomics Plc 14.81%
Holding(s) in Company
19Jan18 10:20 Physiomics Plc 14.81%
Holding(s) in Company
17Jan18 15:52 Physiomics Plc 14.81%
Holding(s) in Company
13Dec17 14:06 Physiomics Plc 14.81%
Result of AGM
12Dec17 10:17 Physiomics Plc 14.81%
Director Dealing
06Dec17 15:00 Physiomics Plc 14.81%
Issue of Equity
30Nov17 13:38 Physiomics Plc 14.81%
Share Price Movement
28Nov17 07:00 Physiomics Plc 14.81%
Clinical Project Completion and Services Agreement
09Nov17 07:00 Physiomics Plc 14.81%
Dispatch of Annual Report and Shareholder Circular
16Oct17 07:00 Physiomics Plc 14.81%
Final Results
02Oct17 07:00 Physiomics Plc 14.81%
Company Update
31Jul17 07:00 Physiomics Plc 14.81%
Two New Pre-Clinical Contracts
05May17 07:00 Physiomics Plc 14.81%
Physiomics to Present at BioTrinity 2017
24Mar17 11:15 Physiomics Plc 14.81%
Interim Results Statement
11Jan17 07:00 Physiomics Plc 14.81%
Company Update
06Jan17 07:00 Physiomics Plc 14.81%
Confirmation of Award of Innovate UK Grant
22Dec16 15:31 Physiomics Plc 14.81%
Director Dealing
22Dec16 07:00 Physiomics Plc 14.81%
Issue of Options
16Dec16 13:00 Physiomics Plc 14.81%
Result of AGM
05Dec16 07:00 Physiomics Plc 14.81%
Payment for in-silico modelling of inhibitor
23Nov16 07:00 Physiomics Plc 14.81%
Posting of Financial Results and Notice of AGM
22Nov16 07:00 Physiomics Plc 14.81%
Provisional Award of Innovate UK Grant
27Oct16 15:00 Physiomics Plc 14.81%
Final Results for the year ended 30 June 2016
25Oct16 07:00 Physiomics Plc 14.81%
Directorate Change
28Sep16 07:00 Physiomics Plc 14.81%
Advisor Changes
21Sep16 07:00 Physiomics Plc 14.81%
Placing and Update on Acquisition
07Sep16 12:19 Physiomics Plc 14.81%
Result of GM
22Aug16 07:00 Physiomics Plc 14.81%
Notice of General Meeting
16Aug16 13:05 Physiomics Plc 14.81%
Advisor Changes
16May16 07:00 Physiomics Plc 14.81%
Extensions for Virtual Tumour Project
18Apr16 09:02 Physiomics Plc 14.81%
Physiomics Appoints New Chief Executive Officer
04Apr16 12:12 Physiomics Plc 14.81%
New Speciality Pharma Customer for new Indication
31Mar16 07:01 Physiomics Plc 14.81%
Interim Results Statement
31Mar16 07:00 Physiomics Plc 14.81%
Heads of Terms with BioMoti and Board Changes
22Dec15 12:08 Physiomics Plc 14.81%
Issue of Options
22Dec15 07:00 Physiomics Plc 14.81%
New Speciality Pharma Customer for New Indication
18Dec15 10:57 Physiomics Plc 14.81%
Placing
14Dec15 10:29 Physiomics Plc 14.81%
Result of General Meeting
27Nov15 16:15 Physiomics Plc 14.81%
Notice of General Meeting
10Nov15 07:00 Physiomics Plc 14.81%
Final Results
06Nov15 07:00 Physiomics Plc 14.81%
Strategic Update
12Oct15 07:00 Physiomics Plc 14.81%
4th Large Pharma Customer for Virtual Tumour
09Oct15 07:00 Physiomics Plc 14.81%
Project extension with global pharma company